{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:40:50Z","timestamp":1686530450717},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy with few accepted prognostic factors that limit the efficiency of therapy. The aim of the current study was to assess the clinical and laboratory features of T-cell receptor (TCR) aberrations and early T-cell precursor (ETP) subtype as well as their outcome to therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sixty-three newly diagnosed pediatric T-ALL patients were assessed for the ETP status using immunophenotyping. Screening of TCRA\/D aberrations was done by fluorescent in situ hybridization (FISH). The data were correlated to the patients\u2019 clinical features, response to treatment, and survival rates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seven patients (11%) had ETP-ALL. The ETP-ALL patients were older (<jats:italic>P<\/jats:italic>\u2009=\u20090.013), presented with lower white blood cell (WBC) count (<jats:italic>P<\/jats:italic>\u2009=\u20090.001) and lower percentage of peripheral blood (PB) blast cells (<jats:italic>P<\/jats:italic>\u2009=\u20090.037), more likely to have hyperdiploid karyotype (<jats:italic>P<\/jats:italic>\u2009=\u20090.009), and had been associated with TCRA\/D gene amplification (<jats:italic>P<\/jats:italic>\u2009=\u20090.014) compared to other T-ALL patients. Of note, the same associations had been significantly observed in patients with TCRA\/D gene amplification. Patients with TCRA\/D amplification frequently coincided with TCR\u03b2 aberrations (<jats:italic>P<\/jats:italic>\u2009=\u20090.025). TCR-\u03b2 aberrations were significantly associated with negative MRD at the end of induction compared to TCR-\u03b2-negative patients. There was a nonsignificant trend of ETP-positive cases to have lower overall survival (OS) (<jats:italic>P<\/jats:italic>\u2009=\u20090.06). Patients with TCR aberrations had no significant differences regarding disease-free survival (DFS) or OS rates compared to those with normal TCR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>ETP-ALL patients tend to have increased mortalities. There was no significant impact of TCR aberrations on the survival rates of the patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43046-023-00176-1","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:01:54Z","timestamp":1686528114000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features, laboratory characteristics, and outcome of ETP and TCRA\/D aberrations in pediatric patients with T-acute lymphoblastic leukemia"],"prefix":"10.1186","volume":"35","author":[{"given":"Mona S. El","family":"Ashry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enas","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona S.","family":"Abdellateif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Arafah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa M.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"176_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28719","volume":"68","author":"MA Burns","year":"2021","unstructured":"Burns MA, Place AE, Guti\u00e9rrez A, Forrest S, Stevenson K, et al. Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: results from DFCI ALL Consortium Protocols 05\u2013001 and 11\u2013001. Pediatr Blood Cancer. 2021;68: e28719.","journal-title":"Pediatr Blood Cancer"},{"key":"176_CR2","first-page":"328","volume":"11","author":"S Raimondi","year":"2007","unstructured":"Raimondi S. T-lineage acute lymphoblastic leukemia (T-ALL). Atlas Genet Cytogenet Oncol Haematol. 2007;11:328\u201339.","journal-title":"Atlas Genet Cytogenet Oncol Haematol."},{"issue":"9","key":"176_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","volume":"129","author":"T Girardi","year":"2017","unstructured":"Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129(9):1113\u201323. https:\/\/doi.org\/10.1182\/blood-2016-10-706465.","journal-title":"Blood"},{"key":"176_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40364-021-00347-z","volume":"9","author":"F Tarantini","year":"2021","unstructured":"Tarantini F, Cumbo C, Anelli L, et al. (2021): Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick. Biomarker Res. 2021;9:89.","journal-title":"Biomarker Res"},{"key":"176_CR5","doi-asserted-by":"crossref","unstructured":"Genesca\u0300 E., Morgades M., Montesinos P., Barba P., et al. Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia. Haematologica. 2020;105:e294.","DOI":"10.3324\/haematol.2019.225078"},{"key":"176_CR6","first-page":"1","volume":"11","author":"O Puglianini","year":"2020","unstructured":"Puglianini O, Papadantonakis N. Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts. Ther Adv Hematol. 2020;11:1\u201313.","journal-title":"Ther Adv Hematol"},{"issue":"5","key":"176_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nri2304","volume":"8","author":"I Aifantis","year":"2008","unstructured":"Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol. 2008;8(5):380\u201390. https:\/\/doi.org\/10.1038\/nri2304.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"176_CR8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/gcc.20684","volume":"48","author":"K Karrman","year":"2009","unstructured":"Karrman K, Forestier E, Heyman M, et al. Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome. Genes chromosomes Cancer. 2009;48(9):795\u2013805. https:\/\/doi.org\/10.1002\/gcc.20684.","journal-title":"Genes chromosomes Cancer"},{"issue":"2","key":"176_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/gcc.22416","volume":"56","author":"K Karrman","year":"2017","unstructured":"Karrman K, Johansson B. Pediatric T-cell acute lymphoblastic leukemia. Genes Chromosom Cancer. 2017;56(2):89\u2013116. https:\/\/doi.org\/10.1002\/gcc.22416.","journal-title":"Genes Chromosom Cancer"},{"key":"176_CR10","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1182\/blood-2014-04-567636","volume":"124","author":"J Bond","year":"2014","unstructured":"Bond J, Bergon A, Durand A, Tigaud I, et al. Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL. Blood. 2014;124:3023\u20135.","journal-title":"Blood"},{"issue":"14","key":"176_CR11","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","volume":"30","author":"SP Hunger","year":"2012","unstructured":"Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children\u2019s oncology group. J Clin Oncol. 2012;30(14):1663\u20139.","journal-title":"J Clin Oncol"},{"issue":"12","key":"176_CR12","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3324\/haematol.2015.125583","volume":"100","author":"DM Hoed","year":"2015","unstructured":"Hoed DM, Pluijm SMF, te Winkel ML, et al. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia. Haematologica. 2015;100(12):1564\u201370.","journal-title":"Haematologica"},{"issue":"7","key":"176_CR13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","volume":"126","author":"MR Litzow","year":"2015","unstructured":"Litzow MR. How we treat T-cell acute lymphoblastic leukemia in adults. Blood. 2015;126(7):833\u201341.","journal-title":"Blood"},{"issue":"6","key":"176_CR14","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","volume":"14","author":"D Bhojwani","year":"2013","unstructured":"Bhojwani D, Pui C-H. Relapsed childhood acute lymphoblastic leukaemia. Lancet Oncol. 2013;14(6):e205\u201317.","journal-title":"Lancet Oncol"},{"key":"176_CR15","doi-asserted-by":"publisher","unstructured":"McGowan-Jordan J, Hastings R, Moore S.. Re: International System for Human Cytogenetic or Cytogenomic Nomenclature (ISCN): Some Thoughts, by T. Liehr.\u00a0Cytogenet Genome Res. 2021;161(5):225\u20136. https:\/\/doi.org\/10.1159\/000516655.","DOI":"10.1159\/000516655"},{"key":"176_CR16","doi-asserted-by":"publisher","unstructured":"McGowan-Jordan J, Hastings Ros J. and Moore S. ISCN 2020: An International System for Human Cytogenomic Nomenclature. 2020. https:\/\/doi.org\/10.1159\/isbn.978-3-318-06867-2.","DOI":"10.1159\/isbn.978-3-318-06867-2"},{"key":"176_CR17","doi-asserted-by":"publisher","unstructured":"Pui CH, Relling MV, Sandlund JT, Downing JR, Campana D, Evans WE. Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol. 2004;83 Suppl 1:S124\u20136. https:\/\/doi.org\/10.1007\/s00277-004-0850-2.","DOI":"10.1007\/s00277-004-0850-2"},{"key":"176_CR18","doi-asserted-by":"publisher","unstructured":"Pui CH, Campana D, Pei D et al. Treatment of childhood acute lymphoblastic leukemia without prophylactic cranial irradiation. N Engl J Med. 2009;360(26): 2730\u201341. https:\/\/doi.org\/10.1056\/NEJMoa0900386.","DOI":"10.1056\/NEJMoa0900386"},{"issue":"2","key":"176_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Mihaela OM, et al. Early t-cell precursor leukemia: a subtype of very high-risk acute lymphoblastic leukemia identified in two independent cohorts. Lancet oncol. 2009;10(2):147\u201356. https:\/\/doi.org\/10.1016\/s1470-2045(08)70314-0.","journal-title":"Lancet oncol"},{"issue":"20","key":"176_CR20","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood"},{"key":"176_CR21","doi-asserted-by":"crossref","unstructured":"Zuurbier L., Gutierrez A., Mullighan C., et al. Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors. Haematologica. 2014;99(1):94\u2013102.","DOI":"10.3324\/haematol.2013.090233"},{"key":"176_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ajh.26144","volume":"96","author":"K Morita","year":"2021","unstructured":"Morita K, Jain N, Kantarjian H, et al. Outcome of T-cell acute lymphoblastic leukemia\/lymphoma: focus on near-ETP phenotype and differential impact of nelarabine. Am J Hematol. 2021;96:589\u201398.","journal-title":"Am J Hematol"},{"issue":"21","key":"176_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood.V124.21.1.1","volume":"124","author":"BL Wood","year":"2014","unstructured":"Wood BL, Winter SS, Dunsmore KP, Devidas M, et al. T-lymphoblastic leukemia (T-ALL) shows excellent outcome, lack of significance of the early thymic precursor (ETP) immunophenotype, and validation of the prognostic value of end-induction minimal residual disease (MRD) in Children\u2019s Oncology Group (COG) study AALL0434. Blood. 2014;124(21):1.","journal-title":"Blood"},{"issue":"15","key":"176_CR24","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","volume":"127","author":"N Jain","year":"2016","unstructured":"Jain N, Lamb AV, O\u2019Brien S. Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016;127(15):1863\u20139.","journal-title":"Blood"},{"key":"176_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/bjh.12882","volume":"166","author":"K Patrick","year":"2014","unstructured":"Patrick K, Wade R, Goulden N, Mitchell C, et al. Outcome for children and young people with Early T-cellprecursor acute lymphoblastic leukaemia treated on acontemporary protocol, UKALL 2003. Br J Haematol. 2014;166:421\u20134.","journal-title":"Br J Haematol"},{"key":"176_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fonc.2019.00316","volume":"9","author":"EP Noronha","year":"2019","unstructured":"Noronha EP, Marques LV, Andrade FG, et al. The profile of immunophenotype and genetic aberrations in subsets of pediatric T-acute lymphoblastic leukemia. Front Oncol. 2019;9:316\u201325.","journal-title":"Front Oncol"},{"issue":"11","key":"176_CR27","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/biomedicines9111621","volume":"9","author":"P Shiraz","year":"2021","unstructured":"Shiraz P, Jehangir W, Agrawal V. T-cell acute lymphoblastic leukemia current concepts in molecular biology and management. Biomedicines. 2021;9(11):1621.","journal-title":"Biomedicines"},{"key":"176_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3343\/alm.2019.39.2.125","volume":"39","author":"H Kim","year":"2019","unstructured":"Kim H, Kim I, Chang C, Kong SY, et al. T-cell receptor rearrangements determined using fragment analysis in patients with T-acute lymphoblastic leukemia. Ann Lab Med. 2019;39:125\u201332.","journal-title":"Ann Lab Med"},{"issue":"8","key":"176_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.it.2021.06.005","volume":"42","author":"A Dutta","year":"2021","unstructured":"Dutta A, Zhao B, Love PE. New insights into TCR \u03b2-selection. Trends Immunol. 2021;42(8):735\u201350. https:\/\/doi.org\/10.1016\/j.it.2021.06.005.","journal-title":"Trends Immunol"},{"issue":"4","key":"176_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.leu.2403263","volume":"18","author":"M Br\u00fcggemann","year":"2004","unstructured":"Br\u00fcggemann M, van der Velden VH, Raff T, Droese J, Ritgen M, et al. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia. Leukemia. 2004;18(4):709\u201319. https:\/\/doi.org\/10.1038\/sj.leu.2403263.","journal-title":"Leukemia"},{"issue":"4","key":"176_CR31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3109\/10428191003660631","volume":"51","author":"YL Chen","year":"2010","unstructured":"Chen YL, Su IJ, Cheng HY, et al. BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan. Leuk Lymphoma. 2010;51(4):650\u20135.","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-023-00176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-023-00176-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-023-00176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:03:13Z","timestamp":1686528193000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-023-00176-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["176"],"URL":"https:\/\/doi.org\/10.1186\/s43046-023-00176-1","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"15 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of the National Cancer Institute, Cairo University, which was in accordance with the 2011 Declaration of Helsinki. All patients\u2019 guardians provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written informed consent was obtained from the patients\u2019 guardians for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}